Talvy | $2,000,000 | (Mar 11, 2026)
Unreasonable Labs | $13,500,000 | (Mar 11, 2026)
Sigma360 | $17,000,000 | (Mar 11, 2026)
Nucleus RadioPharma
United States
- Rochester, MN
- 18/10/2023
- Series A
- $56,000,000
Transforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise. Nucleus bridges the gap between innovation and clinic.
- Industry Pharmaceutical Manufacturing
- Website https://nucleusrad.com/
- LinkedIn https://www.linkedin.com/company/nucleus-radiopharma/about/
Related People
Charles ConroyFounder
United States -
Charlotte Metro
Contact: csconroyrph@gmail.com
Skilled negotiator and decision maker with excellent leadership, problem solving and relationship building skills. Expertise includes:
• Specialty Pharmacy
• Pharmacy Operations Management
• Business Development
• Product Development and Launch
• Alliance Management
• Strategic Planning
• Market Planning
• Corporate and Product Strategy
• Team Leadership and Development
• Acquisition Integration
• Operational Improvement
Specialties: Strategic Development, Pharmaceutical Marketing, Medical Device Marketing, Contract Negotiation, Nuclear Medicine, Process Management, New Business Start-up, Acquisitions, Mergers, Divestitures, Six Sigma, Sterile Compounding, Pharmaceutical Compounding, 340B, Supply Chain, Supply Chain Management
R2 Wireless | $5,000,000 | (Mar 11, 2026)
Verdant Impact | $3,000,000 | (Mar 11, 2026)
Imperium Technologies, Inc | $2,000,000 | (Mar 11, 2026)
Lux Aeterna | $10,000,000 | (Mar 11, 2026)
Amigo | $11,000,000 | (Mar 11, 2026)
Axiom Trust Company | $11,800,000 | (Mar 11, 2026)
Sandbar | $23,000,000 | (Mar 11, 2026)
Jazz | $61,000,000 | (Mar 11, 2026)
PactFi | $25,000,000 | (Mar 11, 2026)